Clinical trials
Phase 1/2 Stomach Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 13 |
| Unknown status | 13 |
| Active, not recruiting | 8 |
| Terminated | 5 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yonsei University | 9 |
| Asan Medical Center | 6 |
| AstraZeneca | 4 |
| Seoul National University Bundang Hospital | 3 |
| Amgen | 2 |
| Bolt Biotherapeutics, Inc. | 2 |
| Hanmi Pharmaceutical Company Limited | 2 |
| MedPacto, Inc. | 2 |
| Samsung Medical Center | 2 |
| Artiva Biotherapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 63 |
| Breast Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Colorectal Neoplasms | 8 |
| Neoplasms | 7 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Biliary Tract Neoplasms | 5 |
| Esophageal Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
Trials
Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.